Bsd Medical Corp (BSDM) 0.62 $BSDM
Global Tumor Ablation Market 2015-2019 - Market Segmentation By Ablation Technology & Cancer Types
M2 - Mon Jan 11, 4:51AM CST
Research and Markets (http://www.researchandmarkets.com/research/nxwf2k/global_tumor) has announced the addition of the "Global Tumor Ablation Market 2015-2019" report to their offering. Tumor ablation is a minimally invasive, image-guided treatment procedure that is used to destroy cancer cells in the chest, lung, and liver. Recent advances in semiconductor technology and modifications to the design of medical laser systems such as MRI or ultrasound are responsible for this markets healthy growth rate of more than 15% during the forecast period. Geographically, the EMEA region is expected to account for the highest market share during the forecast period. The growing prevalence of cancer in countries such as Denmark, Belgium, France, and Norway is responsible for this regions high market share of close to 37% by 2019. Segmentation by ablation technology and analysis of the tumor ablation market: - Radiofrequency - Ultrasound - Cryotherapy - Microwave The report estimates the radiofrequency segment to account for approximately 13% of the total market share by 2019. Radiofrequency is very specific for treating target tissues without causing significant damage to surrounding healthy cells. The high efficacy rate of this procedure is expected to bolster its growth during the forecast period. Companies Mentioned: - AngioDynamics - Boston Scientific - Ethicon - Medtronic - Alpinion Medical System - BSD Medical - Conmed - C2 Therapeutics - CSA Medical - C.R. Bard - Chongqing Haifu Medical Technology - Esaote - EDAP TMS - Galil Medical - InSightec - Misonix - Mermaid Medical - Monteris Key Topics Covered: PART 01: Executive summary PART 02: Scope of the report PART 03: Market research methodology PART 04: Introduction PART 05: Cancer statistics PART 06: Pipeline analysis PART 07: Market landscape PART 08: Market segmentation by ablation technology PART 09: Market segmentation by cancer types PART 10: Geographical segmentation PART 11: Market drivers PART 12: Impact of drivers PART 13: Market challenges PART 14: Impact of drivers and challenges PART 15: Market trends PART 16: Vendor landscape PART 17: Key vendor analysis For more information visit http://www.researchandmarkets.com/research/nx...obal_tumor
BSX: 24.33 (+0.51), MDT: 86.98 (-0.05), MSON: 6.11 (+0.03), BSDM: 0.62 (+0.13)
Global Oncology Ablation Market Outlook 2014-2020
M2 - Tue Apr 14, 9:04AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ksr667/global_oncology) has announced the addition of the "Global Oncology Ablation Market Outlook: 2014-2020" report to their offering. The research report titled Global Oncology Ablation Market Outlook: 2014-2020 provides in-depth analysis of oncology ablation market in four major geographies. The report also emphasizes on the current trends in oncology ablation, market size, market share, recent developments, and forecasts till 2020. Oncology Ablation is the minimal invasive treatment that is used to destroy or inactive the cancer cells and tumors. The market for oncology ablation is on the rise due to increasing number of cancer diagnosis and high acceptance rate among the cancer community across the world. Over the traditional treatment, oncology ablation has many advantages as it is minimal invasive treatment that makes the recovery easy and quick; also it provides relief to patients who are reluctant to go for a surgery. Image guided ablation treatments promises the accuracy in destruction of tumor cells without damaging the uninfected cells. The study offers a comprehensive analysis of oncology ablation market with respect to various technologies and type of cancer. The technologies analyzed in this report are radiofrequency ablation, microwave ablation, cryoablation, ethanol ablation, irreversible electroporesis (IRE), light (laser ablation), and ultrasound ablation; whereas, the cancer types analyzed in the report are lung cancer, liver cancer, breast cancer, kidney cancer, colorectal cancer and prostate cancer. Comprehensive geographical analysis of the oncology ablation is provided by segmenting the global market on the basis of major continents, namely, North America, Europe, Asia Pacific, and RoW (Rest of the World) which are further analyzed at a country level. The report offers meticulous analysis of market dynamics, burning issues, and technological landscape of the global oncology ablation market. The report provides the competitive landscape of the major players in this market with detailed analysis of their product portfolio, financials, and recent developments. Key Topics Covered: 1 Introduction to Global Oncology Ablation Market 2 Executive Summary 3 Market Insights 4 Global Oncology Ablation Market, By Technology 5 Global Oncology Ablation Market, By Type Of Cancer 6 Oncology Ablation Market, By Geography 7 Competitive Landscape- Global Oncology Ablation Market 8 Company Profiles - APRO KOREA - Accuray Inc. - AngioDynamics - BSD Medical - Boston Scientific - Celon AG (Olympus) - Covidien - Elekta AB - Galil Medical - HealthTronics Inc. - MedWaves Incorporated - Misonix Inc. - NeuWave Medical - RF Medical Co. Ltd - STARMed Co. Ltd - SonaCare Medical - Varian Medical Systems For more information visit http://www.researchandmarkets.com/research/ks...l_oncology
BSX: 24.33 (+0.51), VAR: 95.89 (-0.24), MSON: 6.11 (+0.03), BSDM: 0.62 (+0.13), ARAY: 5.30 (-0.03)
Pyrexar Medical Acquires Hyperthermia Assets of BSD Medical
PR Newswire Europe - Thu Apr 02, 1:28PM CDT
-- Promising Cancer Treatment Technology Now Under New Leadership
BSDM: 0.62 (+0.13)
BSD Medical Corporation Announces Appointment of Ben Beckham as Vice President of North American Sales
GlobeNewswire - Tue Feb 17, 8:50AM CST
BSD Medical Corporation (Nasdaq:BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced the appointment of Ben Beckham as Vice President of North American Sales, effective February 16, 2015. Mr. Beckham is an accomplished and performance-driven life sciences executive with over 20 years of experience in medical sales management and marketing.
BSDM: 0.62 (+0.13)
BSD Medical Corporation Announces Changes to Its Board of Directors
GlobeNewswire - Mon Feb 09, 8:15AM CST
BSD Medical Corporation (Nasdaq:BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced the resignation of Gerhard W. Sennewald, Ph.D., and Douglas P. Boyd, Ph.D., as members of the Board of Directors. Mr. Boyd's resignation was effective on January 28, 2015 and Mr. Sennewald's resignation was effective February 4, 2015.
BSDM: 0.62 (+0.13)
BSD Medical Corporation Provides Progress Update on Strategic Plan
GlobeNewswire - Thu Jan 29, 11:45AM CST
-- Submits non-binding term sheet for hyperthermia assets
BSDM: 0.62 (+0.13)
BSD Medical Corporation Reports First Quarter 2015 Financial Results
GlobeNewswire - Thu Jan 15, 8:15AM CST
BSD Medical Corporation (Nasdaq:BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today reported financial results for the fiscal first quarter of 2015 ended November 30, 2014.
BSDM: 0.62 (+0.13)
BSD Medical Corporation Outlines Strategy and Revenue Targets for Microwave Ablation Solutions
GlobeNewswire - Mon Jan 12, 8:16AM CST
BSD Medical Corporation (Nasdaq:BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced its strategic plans and initial revenue targets for the upcoming three-year period. The announcement was made in advance of investor and analyst meetings BSD management is holding this week in the San Francisco Bay Area, concluding with an Investor & Analyst Update Call on Thursday, January 15, 2015 at 2:00 p.m. Eastern time/12:00 p.m. Mountain time. A copy of the material presented may be found in the Investor Relations section on the Company's website.
BSDM: 0.62 (+0.13)
BSD Medical Corporation Announces Investor & Analyst Conference Call
GlobeNewswire - Mon Dec 29, 8:15AM CST
BSD Medical Corporation (Nasdaq:BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced that BSD's new CEO, Clint Carnell, will host an Investor & Analyst Update Call outlining BSD's three year strategic vision on Thursday, January 15, 2015 at 2:00 p.m. Eastern time/12:00 p.m. Mountain time.
BSDM: 0.62 (+0.13)
Mexico Gynecological Devices Market Outlook to 2020: Key players covered include Bayer, Hologic, Boston Scientific, Microsulis, Cook and Merit
M2 - Fri Dec 12, 4:23AM CST
Research and Markets (http://www.researchandmarkets.com/research/g2z4fj/mexico) has announced the addition of the "Mexico Gynecological Devices Market Outlook to 2020" report to their offering. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Gynecological Devices market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Key Topics Covered: 1 List of Tables 2 Introduction 3 Gynecological Devices Market, Mexico 4 Overview of Key Companies in Mexico, Gynecological Devices Market 5 Appendix Companies Mentioned: - Conceptus, Inc. - Hologic, Inc. - CooperSurgical, Inc. - Utah Medical Products, Inc. - Merit Medical Systems, Inc. - Johnson & Johnson - Boston Scientific Corporation - Cook Group Incorporated - BSD Medical Corporation For more information visit http://www.researchandmarkets.com/research/g2z4fj/mexico
BSX: 24.33 (+0.51), JNJ: 119.08 (-0.26), BSDM: 0.62 (+0.13), UTMD: 63.50 (+0.49), MMSI: 24.40 (+0.16), HOLX: 38.46 (+0.04)
EU5 Gynecological Devices Market Outlook to 2020: Key players covered include Bayer, Hologic, Boston Scientific, Microsulis, Cook and Merit
M2 - Tue Dec 09, 3:30AM CST
Research and Markets (http://www.researchandmarkets.com/research/r9xj88/eu5_gynecological) has announced the addition of the "EU5 Gynecological Devices Market Outlook to 2020" report to their offering. Our new report, "EU5 Gynecological Devices Market Outlook to 2020", provides key market data on the EU5 Gynecological Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and Rings)), Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), Bipolar Energy, Cryotherapy and Microwave Endometrial Ablation Devices) and Uterine Fibroid Embolization Agents (Poly Vinyl Alcohol Particles, Trisacryl Gelatin Microspheres and Gelatin Sponge). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Gynecological Devices market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Key Topics Covered: 1 List of Tables 2 Introduction 3 Gynecological Devices Market, EU5 4 Gynecological Devices Market, France 5 Gynecological Devices Market, Germany 6 Gynecological Devices Market, Italy 7 Gynecological Devices Market, Spain 8 Gynecological Devices Market, United Kingdom 9 Overview of Key Companies in EU5 Gynecological Devices Market 10 Appendix Companies Mentioned: - Conceptus, Inc. - Merit Medical Systems, Inc. - Hologic, Inc. - Boston Scientific Corporation - Utah Medical Products, Inc. - CooperSurgical, Inc. - Johnson & Johnson - Cook Group Incorporated - BSD Medical Corporation For more information visit http://www.researchandmarkets.com/research/r9...ecological
BSX: 24.33 (+0.51), JNJ: 119.08 (-0.26), BSDM: 0.62 (+0.13), UTMD: 63.50 (+0.49), MMSI: 24.40 (+0.16), HOLX: 38.46 (+0.04)
United Kingdom Gynecological Devices Market Outlook to 2020
M2 - Tue Dec 02, 5:38AM CST
Research and Markets (http://www.researchandmarkets.com/research/kln7x5/united_kingdom) has announced the addition of the "United Kingdom Gynecological Devices Market Outlook to 2020" report to their offering. "United Kingdom Gynecological Devices Market Outlook to 2020", provides key market data on the United Kingdom Gynecological Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Gynecological Devices market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Scope - Market size data for Gynecological Devices market segments - Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and Rings)), Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), Bipolar Energy, Cryotherapy and Microwave Endometrial Ablation Devices) and Uterine Fibroid Embolization Agents (Poly Vinyl Alcohol Particles, Trisacryl Gelatin Microspheres and Gelatin Sponge). - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Gynecological Devices market. - Global corporate-level profiles of key companies operating within the Gynecological Devices market. - Key players covered include Bayer Healthcare, Hologic, Boston Scientific, Microsulis Medical Limited, Cook Medical and Merit Medical. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Gynecological Devices Market, United Kingdom 4 Overview of Key Companies in United Kingdom, Gynecological Devices Market 5 Appendix Companies Mentioned - Hologic, Inc. - Conceptus, Inc. - Utah Medical Products, Inc. - Merit Medical Systems, Inc. - Boston Scientific Corporation - CooperSurgical, Inc. - Cook Group Incorporated - Johnson & Johnson - BSD Medical Corporation For more information visit http://www.researchandmarkets.com/research/kl...ed_kingdom
BSX: 24.33 (+0.51), JNJ: 119.08 (-0.26), BSDM: 0.62 (+0.13), UTMD: 63.50 (+0.49), MMSI: 24.40 (+0.16), HOLX: 38.46 (+0.04)
BSD Medical Announces Fiscal Year 2014 Financial Results
BusinessWire - Thu Nov 13, 8:15AM CST
BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a provider of medical systems that treat cancer and benign diseases using heat therapy, today reported financial results for its fiscal year ended August 31, 2014.
BSDM: 0.62 (+0.13)
BSD Medical Names Medical Device Veteran Clint Carnell President and Chief Executive Officer
BusinessWire - Mon Nov 10, 7:30AM CST
BSD Medical Corporation (NASDAQ: BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced that its Board of Directors has appointed Clint Carnell, 45, President, Chief Executive Officer, and member of the Board of Directors, effective immediately. Carnell succeeds Harold (Butch) R. Wolcott, who announced in April 2014 his intent to step down as CEO upon the hiring of a successor.
BSDM: 0.62 (+0.13)
Global Tumor Ablation Market 2015-2019 - Market Segmentation By Ablation Technology & Cancer Types
M2 - Mon Jan 11, 4:51AM CST
Research and Markets (http://www.researchandmarkets.com/research/nxwf2k/global_tumor) has announced the addition of the "Global Tumor Ablation Market 2015-2019" report to their offering. Tumor ablation is a minimally invasive, image-guided treatment procedure that is used to destroy cancer cells in the chest, lung, and liver. Recent advances in semiconductor technology and modifications to the design of medical laser systems such as MRI or ultrasound are responsible for this markets healthy growth rate of more than 15% during the forecast period. Geographically, the EMEA region is expected to account for the highest market share during the forecast period. The growing prevalence of cancer in countries such as Denmark, Belgium, France, and Norway is responsible for this regions high market share of close to 37% by 2019. Segmentation by ablation technology and analysis of the tumor ablation market: - Radiofrequency - Ultrasound - Cryotherapy - Microwave The report estimates the radiofrequency segment to account for approximately 13% of the total market share by 2019. Radiofrequency is very specific for treating target tissues without causing significant damage to surrounding healthy cells. The high efficacy rate of this procedure is expected to bolster its growth during the forecast period. Companies Mentioned: - AngioDynamics - Boston Scientific - Ethicon - Medtronic - Alpinion Medical System - BSD Medical - Conmed - C2 Therapeutics - CSA Medical - C.R. Bard - Chongqing Haifu Medical Technology - Esaote - EDAP TMS - Galil Medical - InSightec - Misonix - Mermaid Medical - Monteris Key Topics Covered: PART 01: Executive summary PART 02: Scope of the report PART 03: Market research methodology PART 04: Introduction PART 05: Cancer statistics PART 06: Pipeline analysis PART 07: Market landscape PART 08: Market segmentation by ablation technology PART 09: Market segmentation by cancer types PART 10: Geographical segmentation PART 11: Market drivers PART 12: Impact of drivers PART 13: Market challenges PART 14: Impact of drivers and challenges PART 15: Market trends PART 16: Vendor landscape PART 17: Key vendor analysis For more information visit http://www.researchandmarkets.com/research/nx...obal_tumor
BSX: 24.33 (+0.51), MDT: 86.98 (-0.05), MSON: 6.11 (+0.03), BSDM: 0.62 (+0.13)
Global Oncology Ablation Market Outlook 2014-2020
M2 - Tue Apr 14, 9:04AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ksr667/global_oncology) has announced the addition of the "Global Oncology Ablation Market Outlook: 2014-2020" report to their offering. The research report titled Global Oncology Ablation Market Outlook: 2014-2020 provides in-depth analysis of oncology ablation market in four major geographies. The report also emphasizes on the current trends in oncology ablation, market size, market share, recent developments, and forecasts till 2020. Oncology Ablation is the minimal invasive treatment that is used to destroy or inactive the cancer cells and tumors. The market for oncology ablation is on the rise due to increasing number of cancer diagnosis and high acceptance rate among the cancer community across the world. Over the traditional treatment, oncology ablation has many advantages as it is minimal invasive treatment that makes the recovery easy and quick; also it provides relief to patients who are reluctant to go for a surgery. Image guided ablation treatments promises the accuracy in destruction of tumor cells without damaging the uninfected cells. The study offers a comprehensive analysis of oncology ablation market with respect to various technologies and type of cancer. The technologies analyzed in this report are radiofrequency ablation, microwave ablation, cryoablation, ethanol ablation, irreversible electroporesis (IRE), light (laser ablation), and ultrasound ablation; whereas, the cancer types analyzed in the report are lung cancer, liver cancer, breast cancer, kidney cancer, colorectal cancer and prostate cancer. Comprehensive geographical analysis of the oncology ablation is provided by segmenting the global market on the basis of major continents, namely, North America, Europe, Asia Pacific, and RoW (Rest of the World) which are further analyzed at a country level. The report offers meticulous analysis of market dynamics, burning issues, and technological landscape of the global oncology ablation market. The report provides the competitive landscape of the major players in this market with detailed analysis of their product portfolio, financials, and recent developments. Key Topics Covered: 1 Introduction to Global Oncology Ablation Market 2 Executive Summary 3 Market Insights 4 Global Oncology Ablation Market, By Technology 5 Global Oncology Ablation Market, By Type Of Cancer 6 Oncology Ablation Market, By Geography 7 Competitive Landscape- Global Oncology Ablation Market 8 Company Profiles - APRO KOREA - Accuray Inc. - AngioDynamics - BSD Medical - Boston Scientific - Celon AG (Olympus) - Covidien - Elekta AB - Galil Medical - HealthTronics Inc. - MedWaves Incorporated - Misonix Inc. - NeuWave Medical - RF Medical Co. Ltd - STARMed Co. Ltd - SonaCare Medical - Varian Medical Systems For more information visit http://www.researchandmarkets.com/research/ks...l_oncology
BSX: 24.33 (+0.51), VAR: 95.89 (-0.24), MSON: 6.11 (+0.03), BSDM: 0.62 (+0.13), ARAY: 5.30 (-0.03)
Pyrexar Medical Acquires Hyperthermia Assets of BSD Medical
PR Newswire Europe - Thu Apr 02, 1:28PM CDT
-- Promising Cancer Treatment Technology Now Under New Leadership
BSDM: 0.62 (+0.13)
BSD Medical Corporation Announces Appointment of Ben Beckham as Vice President of North American Sales
GlobeNewswire - Tue Feb 17, 8:50AM CST
BSD Medical Corporation (Nasdaq:BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced the appointment of Ben Beckham as Vice President of North American Sales, effective February 16, 2015. Mr. Beckham is an accomplished and performance-driven life sciences executive with over 20 years of experience in medical sales management and marketing.
BSDM: 0.62 (+0.13)
BSD Medical Corporation Announces Changes to Its Board of Directors
GlobeNewswire - Mon Feb 09, 8:15AM CST
BSD Medical Corporation (Nasdaq:BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced the resignation of Gerhard W. Sennewald, Ph.D., and Douglas P. Boyd, Ph.D., as members of the Board of Directors. Mr. Boyd's resignation was effective on January 28, 2015 and Mr. Sennewald's resignation was effective February 4, 2015.
BSDM: 0.62 (+0.13)
BSD Medical Corporation Provides Progress Update on Strategic Plan
GlobeNewswire - Thu Jan 29, 11:45AM CST
-- Submits non-binding term sheet for hyperthermia assets
BSDM: 0.62 (+0.13)
BSD Medical Corporation Reports First Quarter 2015 Financial Results
GlobeNewswire - Thu Jan 15, 8:15AM CST
BSD Medical Corporation (Nasdaq:BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today reported financial results for the fiscal first quarter of 2015 ended November 30, 2014.
BSDM: 0.62 (+0.13)
BSD Medical Corporation Outlines Strategy and Revenue Targets for Microwave Ablation Solutions
GlobeNewswire - Mon Jan 12, 8:16AM CST
BSD Medical Corporation (Nasdaq:BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced its strategic plans and initial revenue targets for the upcoming three-year period. The announcement was made in advance of investor and analyst meetings BSD management is holding this week in the San Francisco Bay Area, concluding with an Investor & Analyst Update Call on Thursday, January 15, 2015 at 2:00 p.m. Eastern time/12:00 p.m. Mountain time. A copy of the material presented may be found in the Investor Relations section on the Company's website.
BSDM: 0.62 (+0.13)
BSD Medical Corporation Announces Investor & Analyst Conference Call
GlobeNewswire - Mon Dec 29, 8:15AM CST
BSD Medical Corporation (Nasdaq:BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced that BSD's new CEO, Clint Carnell, will host an Investor & Analyst Update Call outlining BSD's three year strategic vision on Thursday, January 15, 2015 at 2:00 p.m. Eastern time/12:00 p.m. Mountain time.
BSDM: 0.62 (+0.13)
Mexico Gynecological Devices Market Outlook to 2020: Key players covered include Bayer, Hologic, Boston Scientific, Microsulis, Cook and Merit
M2 - Fri Dec 12, 4:23AM CST
Research and Markets (http://www.researchandmarkets.com/research/g2z4fj/mexico) has announced the addition of the "Mexico Gynecological Devices Market Outlook to 2020" report to their offering. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Gynecological Devices market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Key Topics Covered: 1 List of Tables 2 Introduction 3 Gynecological Devices Market, Mexico 4 Overview of Key Companies in Mexico, Gynecological Devices Market 5 Appendix Companies Mentioned: - Conceptus, Inc. - Hologic, Inc. - CooperSurgical, Inc. - Utah Medical Products, Inc. - Merit Medical Systems, Inc. - Johnson & Johnson - Boston Scientific Corporation - Cook Group Incorporated - BSD Medical Corporation For more information visit http://www.researchandmarkets.com/research/g2z4fj/mexico
BSX: 24.33 (+0.51), JNJ: 119.08 (-0.26), BSDM: 0.62 (+0.13), UTMD: 63.50 (+0.49), MMSI: 24.40 (+0.16), HOLX: 38.46 (+0.04)
EU5 Gynecological Devices Market Outlook to 2020: Key players covered include Bayer, Hologic, Boston Scientific, Microsulis, Cook and Merit
M2 - Tue Dec 09, 3:30AM CST
Research and Markets (http://www.researchandmarkets.com/research/r9xj88/eu5_gynecological) has announced the addition of the "EU5 Gynecological Devices Market Outlook to 2020" report to their offering. Our new report, "EU5 Gynecological Devices Market Outlook to 2020", provides key market data on the EU5 Gynecological Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and Rings)), Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), Bipolar Energy, Cryotherapy and Microwave Endometrial Ablation Devices) and Uterine Fibroid Embolization Agents (Poly Vinyl Alcohol Particles, Trisacryl Gelatin Microspheres and Gelatin Sponge). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Gynecological Devices market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Key Topics Covered: 1 List of Tables 2 Introduction 3 Gynecological Devices Market, EU5 4 Gynecological Devices Market, France 5 Gynecological Devices Market, Germany 6 Gynecological Devices Market, Italy 7 Gynecological Devices Market, Spain 8 Gynecological Devices Market, United Kingdom 9 Overview of Key Companies in EU5 Gynecological Devices Market 10 Appendix Companies Mentioned: - Conceptus, Inc. - Merit Medical Systems, Inc. - Hologic, Inc. - Boston Scientific Corporation - Utah Medical Products, Inc. - CooperSurgical, Inc. - Johnson & Johnson - Cook Group Incorporated - BSD Medical Corporation For more information visit http://www.researchandmarkets.com/research/r9...ecological
BSX: 24.33 (+0.51), JNJ: 119.08 (-0.26), BSDM: 0.62 (+0.13), UTMD: 63.50 (+0.49), MMSI: 24.40 (+0.16), HOLX: 38.46 (+0.04)
United Kingdom Gynecological Devices Market Outlook to 2020
M2 - Tue Dec 02, 5:38AM CST
Research and Markets (http://www.researchandmarkets.com/research/kln7x5/united_kingdom) has announced the addition of the "United Kingdom Gynecological Devices Market Outlook to 2020" report to their offering. "United Kingdom Gynecological Devices Market Outlook to 2020", provides key market data on the United Kingdom Gynecological Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Gynecological Devices market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Scope - Market size data for Gynecological Devices market segments - Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and Rings)), Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), Bipolar Energy, Cryotherapy and Microwave Endometrial Ablation Devices) and Uterine Fibroid Embolization Agents (Poly Vinyl Alcohol Particles, Trisacryl Gelatin Microspheres and Gelatin Sponge). - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Gynecological Devices market. - Global corporate-level profiles of key companies operating within the Gynecological Devices market. - Key players covered include Bayer Healthcare, Hologic, Boston Scientific, Microsulis Medical Limited, Cook Medical and Merit Medical. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Gynecological Devices Market, United Kingdom 4 Overview of Key Companies in United Kingdom, Gynecological Devices Market 5 Appendix Companies Mentioned - Hologic, Inc. - Conceptus, Inc. - Utah Medical Products, Inc. - Merit Medical Systems, Inc. - Boston Scientific Corporation - CooperSurgical, Inc. - Cook Group Incorporated - Johnson & Johnson - BSD Medical Corporation For more information visit http://www.researchandmarkets.com/research/kl...ed_kingdom
BSX: 24.33 (+0.51), JNJ: 119.08 (-0.26), BSDM: 0.62 (+0.13), UTMD: 63.50 (+0.49), MMSI: 24.40 (+0.16), HOLX: 38.46 (+0.04)
BSD Medical Announces Fiscal Year 2014 Financial Results
BusinessWire - Thu Nov 13, 8:15AM CST
BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a provider of medical systems that treat cancer and benign diseases using heat therapy, today reported financial results for its fiscal year ended August 31, 2014.
BSDM: 0.62 (+0.13)
BSD Medical Names Medical Device Veteran Clint Carnell President and Chief Executive Officer
BusinessWire - Mon Nov 10, 7:30AM CST
BSD Medical Corporation (NASDAQ: BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced that its Board of Directors has appointed Clint Carnell, 45, President, Chief Executive Officer, and member of the Board of Directors, effective immediately. Carnell succeeds Harold (Butch) R. Wolcott, who announced in April 2014 his intent to step down as CEO upon the hiring of a successor.
BSDM: 0.62 (+0.13)
